Skip to main content

Published locations for Tralokinumab improves clinical responses at week 16 in moderate-to-severe AD despite IGA 0/1 nonachievement

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tralokinumab improves clinical responses at week 16 in moderate-to-severe AD despite IGA 0/1 nonachievement

User login

  • Reset your password
  • /content/tralokinumab-improves-clinical-responses-week-16-moderate-severe-ad-despite-iga-0/1
  • /dermatology/article/266011/atopic-dermatitis/tralokinumab-improves-clinical-responses-week-16